Search hospitals > Florida > Miami Beach
Mount Sinai Medical Center
Claim this profileMiami Beach, Florida 33140
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
447 reported clinical trials
19 medical researchers
Summary
Mount Sinai Medical Center is a medical facility located in Miami Beach, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Mount Sinai Medical Center is involved with conducting 447 clinical trials across 474 conditions. There are 19 research doctors associated with this hospital, such as Michael A. Schwartz, Mike Cusnir, MD, Brian Slomovitz, and Oleg Gligich.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Michael A. SchwartzMount Sinai Medical Center7 years of reported clinical research
Studies Cancer
Studies Lung Cancer
27 reported clinical trials
74 drugs studied
Mike Cusnir, MDMount Sinai Medical Center2 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
29 reported clinical trials
57 drugs studied
Brian SlomovitzMount Sinai Comprehensive Cancer Center2 years of reported clinical research
Studies Endometrial Cancer
Studies Ovarian Cancer
16 reported clinical trials
30 drugs studied
Oleg GligichMount Sinai Medical Center1 year of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Cancer
9 reported clinical trials
26 drugs studied
Clinical Trials running at Mount Sinai Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Cancer
Pancreatic Cancer
Prostate Cancer
Urothelial Carcinoma
Renal Cell Carcinoma
Trastuzumab Deruxtecan
for Breast Cancer
This study will evaluate the safety and efficacy of trastuzumab deruxtecan (T-DXd) in participants with human epidermal growth factor receptor 2 (HER2)-low or HER2 immunohistochemistry (IHC) 0 (who are both hormone receptor \[HR\]-negative and HR-positive) unresectable and/or metastatic breast cancer.
Recruiting2 awards Phase 310 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Sinai Medical Center?
Mount Sinai Medical Center is a medical facility located in Miami Beach, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Mount Sinai Medical Center is involved with conducting 447 clinical trials across 474 conditions. There are 19 research doctors associated with this hospital, such as Michael A. Schwartz, Mike Cusnir, MD, Brian Slomovitz, and Oleg Gligich.
Where is Mount Sinai Medical Center located?
**Mount Sinai Medical Center - Miami Beach, FL**
- **Address:** 4300 Alton Rd, Miami Beach, FL
- **Directions:** Take I-195 E to the Alton Road exit. Head south on Alton Road for approximately one mile.
- **Parking:** Visitor parking is available in the parking garage located at the hospital's address.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Mount Sinai Medical Center, patients can contact the Customer Service department at 305-674-2130, available Monday-Friday, 9:00am to 4:00pm. The Resource, Entitlement and Advocacy Program (REAP) assists with government health insurance programs and requires a referral by a Social Worker. The Charity Care Program offers financial aid to eligible patients; for application details, call the Financial Counseling Office at 212-979-4306.
What insurance does Mount Sinai Medical Center accept?
Mount Sinai Medical Center accepts a wide range of insurance plans for urgent care, including but not limited to:
- Various Aetna plans (HMO, PPO/POS, Medicare)
- Cigna plans (HMO, Indemnity, Open Access, POS, PPO/EPO)
- Empire BCBS (PPO/POS/EPO, HMO, Healthy New York, Mediblue, Top Tier)
- EmblemHealth (CBP PPO, CompreHealth NY Metro Network-HIP EPO/HMO)
- HIP (EPO, Healthy NY Plan, HMO-Classic, Medicare Advantage)
- United Healthcare (PPO/POS/EPO, HMO, Empire Plan, Medicare)
- Other plans including 1199 National Benefit Fund, Fidelis, Healthfirst, Magnacare, Medicare, Oscar, Oxford plans, and PHCS/Multiplan.
For the most current insurance information, please contact Mount Sinai Medical Center directly.
What awards or recognition has Mount Sinai Medical Center received?
Mount Sinai Medical Center in Miami Beach, Florida, is renowned for its high-quality care, underscored by numerous awards and recognitions. This institution has been acknowledged by the Agency for Healthcare Research and Quality (AHRQ) for its exceptional quality data. Its commitment to excellence is further bolstered by a robust focus on teaching and research.